New

Uterine Fibroids Market

2021

Uterine Fibroids Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Surgical, Hormonal, Embolization, and Others); End Use (Hospital, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Geography

| Report Code: TIPRE00024418 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Uterine Fibroids Market 2028 By Type, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Uterine Fibroids are generally small benign, non-cancerous tumors that grow in the uterus wall. These are cancerous but do not spread. They differ in size, from the minute inch to an area of more than 16 cm. The number of uterine fibroids is about 20%-40% in women through their reproductive ages. Often, these fibroids swell up and make the uterus develop like full visible pregnancy. Mostly, there is a chance of more than one fibroid in the uterus. Indication of uterine fibroids involves heavy menstrual bleeding, frequent urination, pelvic pain, constipation, and backache or leg pain. The circumstances behind the growth of these tumors can be genetic changes, hormonal imbalance, and other reasons. The treatment includes medications that specifically target hormones, embolization, MRI-guided focused ultrasound surgery (FUS), and hysterectomy.

MARKET SCOPE

The "Global Uterine Fibroids Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Uterine fibroids market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Uterine fibroids market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global Uterine fibroids market is segmented into surgical, hormonal, embolization, others.
  •  On the basis of end use, the market is segmented into hospital, ambulatory surgical centers, diagnostic centers, others.

MARKET DYNAMICS

Drivers:

  •  Rise in the incidences of Uterine Fibroids.
  •  Rise in the demand for minimally or non-invasive uterine fibroid methods.
  •  Growing awareness initiatives related to uterine fibroids diagnosis and treatment.
  •  Technological advancements.

Restraints:

  •  The high treatment cost associated with uterine fibrosis is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Uterine fibroids market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Uterine fibroids market in these regions.

IMPACT OF COVID-19ON UTERINE FIBROIDS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Uterine fibroids market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Uterine fibroids market are anticipated to lucrative growth opportunities in the future with the rising demand for Uterine fibroids in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Uterine fibroids market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Boston Scientific
  •  Cooper Surgical
  •  C.R. Bard
  •  F. Hoffmann-La Roche
  •  GE Healthcare
  •  Karl Storz Endoscopy
  •  Richard Wolf Medical Instruments
  •  Siemens Medical Solutions
  •  AbbVie
  •  AstraZeneca
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Uterine Fibroids Market - By Type
1.3.2 Uterine Fibroids Market - By End Use
1.3.3 Uterine Fibroids Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. UTERINE FIBROIDS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. UTERINE FIBROIDS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. UTERINE FIBROIDS MARKET - GLOBAL MARKET ANALYSIS
6.1. UTERINE FIBROIDS - GLOBAL MARKET OVERVIEW
6.2. UTERINE FIBROIDS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. UTERINE FIBROIDS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SURGICAL
7.3.1. Overview
7.3.2. Surgical Market Forecast and Analysis
7.4. HORMONAL
7.4.1. Overview
7.4.2. Hormonal Market Forecast and Analysis
7.5. EMBOLIZATION
7.5.1. Overview
7.5.2. Embolization Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. UTERINE FIBROIDS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. DIAGNOSTIC CENTERS
8.5.1. Overview
8.5.2. Diagnostic Centers Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. UTERINE FIBROIDS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Uterine Fibroids Market Overview
9.1.2 North America Uterine Fibroids Market Forecasts and Analysis
9.1.3 North America Uterine Fibroids Market Forecasts and Analysis - By Type
9.1.4 North America Uterine Fibroids Market Forecasts and Analysis - By End Use
9.1.5 North America Uterine Fibroids Market Forecasts and Analysis - By Countries
9.1.5.1 United States Uterine Fibroids Market
9.1.5.1.1 United States Uterine Fibroids Market by Type
9.1.5.1.2 United States Uterine Fibroids Market by End Use
9.1.5.2 Canada Uterine Fibroids Market
9.1.5.2.1 Canada Uterine Fibroids Market by Type
9.1.5.2.2 Canada Uterine Fibroids Market by End Use
9.1.5.3 Mexico Uterine Fibroids Market
9.1.5.3.1 Mexico Uterine Fibroids Market by Type
9.1.5.3.2 Mexico Uterine Fibroids Market by End Use
9.2. EUROPE
9.2.1 Europe Uterine Fibroids Market Overview
9.2.2 Europe Uterine Fibroids Market Forecasts and Analysis
9.2.3 Europe Uterine Fibroids Market Forecasts and Analysis - By Type
9.2.4 Europe Uterine Fibroids Market Forecasts and Analysis - By End Use
9.2.5 Europe Uterine Fibroids Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Uterine Fibroids Market
9.2.5.1.1 Germany Uterine Fibroids Market by Type
9.2.5.1.2 Germany Uterine Fibroids Market by End Use
9.2.5.2 France Uterine Fibroids Market
9.2.5.2.1 France Uterine Fibroids Market by Type
9.2.5.2.2 France Uterine Fibroids Market by End Use
9.2.5.3 Italy Uterine Fibroids Market
9.2.5.3.1 Italy Uterine Fibroids Market by Type
9.2.5.3.2 Italy Uterine Fibroids Market by End Use
9.2.5.4 Spain Uterine Fibroids Market
9.2.5.4.1 Spain Uterine Fibroids Market by Type
9.2.5.4.2 Spain Uterine Fibroids Market by End Use
9.2.5.5 United Kingdom Uterine Fibroids Market
9.2.5.5.1 United Kingdom Uterine Fibroids Market by Type
9.2.5.5.2 United Kingdom Uterine Fibroids Market by End Use
9.2.5.6 Rest of Europe Uterine Fibroids Market
9.2.5.6.1 Rest of Europe Uterine Fibroids Market by Type
9.2.5.6.2 Rest of Europe Uterine Fibroids Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Uterine Fibroids Market Overview
9.3.2 Asia-Pacific Uterine Fibroids Market Forecasts and Analysis
9.3.3 Asia-Pacific Uterine Fibroids Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Uterine Fibroids Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Uterine Fibroids Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Uterine Fibroids Market
9.3.5.1.1 Australia Uterine Fibroids Market by Type
9.3.5.1.2 Australia Uterine Fibroids Market by End Use
9.3.5.2 China Uterine Fibroids Market
9.3.5.2.1 China Uterine Fibroids Market by Type
9.3.5.2.2 China Uterine Fibroids Market by End Use
9.3.5.3 India Uterine Fibroids Market
9.3.5.3.1 India Uterine Fibroids Market by Type
9.3.5.3.2 India Uterine Fibroids Market by End Use
9.3.5.4 Japan Uterine Fibroids Market
9.3.5.4.1 Japan Uterine Fibroids Market by Type
9.3.5.4.2 Japan Uterine Fibroids Market by End Use
9.3.5.5 South Korea Uterine Fibroids Market
9.3.5.5.1 South Korea Uterine Fibroids Market by Type
9.3.5.5.2 South Korea Uterine Fibroids Market by End Use
9.3.5.6 Rest of Asia-Pacific Uterine Fibroids Market
9.3.5.6.1 Rest of Asia-Pacific Uterine Fibroids Market by Type
9.3.5.6.2 Rest of Asia-Pacific Uterine Fibroids Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Uterine Fibroids Market Overview
9.4.2 Middle East and Africa Uterine Fibroids Market Forecasts and Analysis
9.4.3 Middle East and Africa Uterine Fibroids Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Uterine Fibroids Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Uterine Fibroids Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Uterine Fibroids Market
9.4.5.1.1 South Africa Uterine Fibroids Market by Type
9.4.5.1.2 South Africa Uterine Fibroids Market by End Use
9.4.5.2 Saudi Arabia Uterine Fibroids Market
9.4.5.2.1 Saudi Arabia Uterine Fibroids Market by Type
9.4.5.2.2 Saudi Arabia Uterine Fibroids Market by End Use
9.4.5.3 U.A.E Uterine Fibroids Market
9.4.5.3.1 U.A.E Uterine Fibroids Market by Type
9.4.5.3.2 U.A.E Uterine Fibroids Market by End Use
9.4.5.4 Rest of Middle East and Africa Uterine Fibroids Market
9.4.5.4.1 Rest of Middle East and Africa Uterine Fibroids Market by Type
9.4.5.4.2 Rest of Middle East and Africa Uterine Fibroids Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Uterine Fibroids Market Overview
9.5.2 South and Central America Uterine Fibroids Market Forecasts and Analysis
9.5.3 South and Central America Uterine Fibroids Market Forecasts and Analysis - By Type
9.5.4 South and Central America Uterine Fibroids Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Uterine Fibroids Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Uterine Fibroids Market
9.5.5.1.1 Brazil Uterine Fibroids Market by Type
9.5.5.1.2 Brazil Uterine Fibroids Market by End Use
9.5.5.2 Argentina Uterine Fibroids Market
9.5.5.2.1 Argentina Uterine Fibroids Market by Type
9.5.5.2.2 Argentina Uterine Fibroids Market by End Use
9.5.5.3 Rest of South and Central America Uterine Fibroids Market
9.5.5.3.1 Rest of South and Central America Uterine Fibroids Market by Type
9.5.5.3.2 Rest of South and Central America Uterine Fibroids Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL UTERINE FIBROIDS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. UTERINE FIBROIDS MARKET, KEY COMPANY PROFILES
12.1. BOSTON SCIENTIFIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. COOPER SURGICAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. C.R. BARD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GE HEALTHCARE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. KARL STORZ ENDOSCOPY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. RICHARD WOLF MEDICAL INSTRUMENTS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SIEMENS MEDICAL SOLUTIONS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ABBVIE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASTRAZENECA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Boston Scientific
2. Cooper Surgical
3. C.R. Bard
4. F. Hoffmann-La Roche
5. GE Healthcare
6. Karl Storz Endoscopy
7. Richard Wolf Medical Instruments
8. Siemens Medical Solutions
9. AbbVie
10. AstraZeneca
11. Bayer
12. Eli Lilly
13. GlaxoSmithKline Pharmaceuticals
14. Pfizer
15. Johnson and Johnson
16. Novartis
TIPRE00024418
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.